ABSTRACT. Caulerpa cupressoides var. lycopodium (Chlorophyta) contains three sulfated polysaccharides (SPs) fractions (SP 1 , SP 2 and SP 3 ); but, their pharmacological properties have been limited. We investigated the antinociceptive activity of non-anticoagulant fraction (SP 1 ) and then its acute toxicological study in male Swiss mice was performed. Animals (19-25 g) received i.v. SP 1 30 min. prior to injection 0.8% acetic acid (10 mL kg -1 , i.p.); 1% formalin (20 μL, i.pl.) or were subjected to thermal stimuli. Open-field test was also performed. Mice were treated i.p. with SP 1 or 0.9% saline (0.1 mL 10 g -1 ) for 72h. On the 4 th day, the animals were anesthetized and sacrificed in order to collect blood and organs. SP 1 (3, 9 or 27 mg kg ) did not cause hepatic or renal dysfunctions, but affected the spleen of animals (p < 0.05). Therefore, SP 1 has analgesic action with high tolerance by the animals, presenting its potential applicability in pain conditions. Keywords: green alga, sulfated sugars, nociception, biochemical analysis.
Introduction
In recent years, the human consumption of seaweeds as food (thickening, gelling and stabilizing, nutrients, etc.) (CAMPO et al., 2009; MARINHO-SORIANO et al., 2006; SMIT, 2004) , and the search for bioactive products (with anticoagulant, antinociceptive, anti-inflammatory effects etc.) POMIN, 2012; RODRIGUES et al., 2011a; VANDERLEI et al., 2010) with minimum adverse effects (ALMEIDA-LIMA et al., 2011; ASSREUY et al., 2008 Smit (2004) , natural products from seaweeds have attracted commercial significance and influenced the modern western societies. Marine algae have been mainly used in medical and biochemical research. Of all seaweed products, sulfated polysaccharides (SPs), including galactan (Rhodophyta) (CAMPO et al., 2009; POMIN, 2012) , fucan or fucoidan (Phaeophyta) (ALMEIDA-LIMA et al., 2011; LI et al., 2005) , and arabinogalactan (Chlorophyta) (GHOSH et al., 2004; HAYAKAWA et al., 2000) , are the most frequently found. These anionic polymers comprise the extracellular matrix of these marine organisms playing an important protective role (ANDRADE et al., 2010) .
Although widely studied as anticoagulant and antithrombotic agents (ALMEIDA-LIMA et al., 2011; LI et al., 2005; , SPs may modulate a large number of other biological activities, including antiviral (GHOSH et al., 2004) , antinociceptive, pro-inflammatory ASSREUY et al., 2008; VIANA et al., 2002) , antitumor (LINS et al., 2009 ) and anti-inflammatory properties . It has been accepted that enzymatic digestion of seaweed results in high bioactive yield and shows biological activity in comparison with water extract (RODRIGUES et al., 2011a) . In addition, the use of enzymes may be useful to extract pharmaceutically important materials without toxicity (HEO et al., 2005) .
The genus Caulerpa Lamouroux (1809) of green seaweed of the family Caulerpaceae encompasses about one hundred species, found in tropical and subtropical waters. Algae from this genus have highly invasive capacity in the marine environment, being important contributors to the algal biomass of coral reefs and lagoons (TRI, 2009 ). Some metabolites with chemotaxonomic and medicinal significance have been isolated (MAO et al., 2011; . In Brazil, some species of this genus have already been registered VANDERLEI et al., 2010) . Anticoagulant, antithrombotic, antitumor, antiviral and prothrombotic activities of the Caulerpa SPs have been described in the literature (GHOSH et al., 2004; HAYAKAWA et al., 2000; JI et al., 2008; RODRIGUES et al., 2011b) . However, there are few studies on the biological potential of Caulerpa SPs. In addition, report in animal models of nociception and locomotion of seaweeds SPs, to the best of our knowledge, has not been associated to data.
Pain promotes an uncomfortable sensation to patients, and may be caused by tissue lesions or by an independent manner, being thus a complex interaction between peripheral and central structure from skin to central cerebral cortex. Tissue damage (due to inflammation or injury) may result in chronic neuropathic pain caused by increased sensitivity to painful stimuli (MOALEM; TRACEY, 2006) . Animal models of nociception have been widely used as important tools for discovering new natural analgesic compounds ASSREUY et al., 2008; VANDERLEI et al., 2010; VIANA et al., 2002) .
The non-steroidal anti-inflammatory drugs are commonly used in the suppression of the inflammatory reaction in medical clinic, having the property to inhibit initial or latter manifestations. However, the prolonged administration of these therapeutic agents is usually followed by complications (gastric perforations, stomach ulcers and bleeding) (IWALEWA et al., 2007) .
Issues about the safety of SPs are still rarely reported (CAMPO et al., 2009; LI et al., 2005; RODRIGUES et al., 2011c) . Almeida-Lima et al. (2011) examined the subchronic toxicity in vivo of a heterofucan (Fucan A) from Spatoglossum schröderi (Phaeophyta) and no toxicologically significant changes were observed in the biochemical or hematological parameters in treated Wistar rats. In the present study, it was investigated the effects of a novel antinociceptive non-anticoagulant SP from C. cupressoides var. lycopodium (Chlorophyta) using experimental animal models of nociception and locomotion. The safety of this compound was also evaluated using an acute toxicity model in Swiss mice.
Material and methods

Experimental design
The crude SP was extracted from C. cupressoides and the antinociceptive activity of a nonanticoagulant fraction (SP 1 ) was tested in vivo with experimental animal models of nociception and locomotion using male mice. The effects on some biochemical parameters were also evaluated in mice treated for 72h using an acute toxicity model.
Marine alga and isolation and chemical composition of SPs
Specimens of the green alga C. cupressoides var. lycopodium (Vahl) C. Agardh (Chlorophyta, Caulerpaceae) were collected (September, 2009) Rodrigues et al. (2011b) .
Animals
Male Swiss mice (19-25 g) were randomly selected from the Animal House of the Federal University of Ceará, maintained on a 12h light/dark cycle, at temperature-controlled rooms and received water and food ad libitum. For the experiments, a total of 246 animals were used. All procedures and animal treatments were conducted in accordance with the guidelines for Institutional Animal Care and Use of the Federal University of Ceará, Ceará State, Brazil, previously approved by 80/10 protocol. In addition, the tested doses and administration route of SP 1 used in the experimental models were determined as previously reported .
Acetic acid-induced writhing test
This test was performed according to Collier et al. (1968) . Groups of six mice received intravenously (i.v.) 0.9% saline (0.2 mL) or SP 1 (3, 9 or 27 mg kg -1 body weight). After 30 min., animals received a 0.8% acetic acid injection (10 mL kg 
Formalin test
This test has been used as a model for tonic pain and localized inflammatory pain (HUNSKAAR et al., 1985) . Groups of six mice received intravenously (i.v.) SP 1 (3, 9 or 27 mg kg (s.c.), were used as standards.
Hot-plate test
This test is also used to measure the antinociceptive activity (EDDY; LEIMBACH, 1953) . Groups of six animals were used. Each mouse was dropped twice on the heated plate (51 ± 1°C), separated by a 30 min. interval. The first trial familiarized the animal with the test procedure and the second served as the control reaction time (licking the paw or jumping). Animals showing a reaction time longer than 10 s were discarded. Immediately after the second trial (control reaction time), groups of six mice each received intravenously (i.v.) 0.9% saline in a volume of 10 mL kg 
Open-field test
This test was performed according to Archer (1973) . The open-field area was made of acrylic transparent walls and black floor (30 × 30 × 15 cm), divided into nine squares of equal area, to evaluate the locomotor activity of the animal for 5 min. The following parameters were observed: number of squares crossed and number of grooming and rearings. The animals were divided into five groups of 8 animals each. The groups were treated with: control saline (0.9%, i.v.), SP 1 (3, 9 or 27 mg kg 
Acute toxicity model
This assay was based on Monji et al. (2011) . Body mass loss, organ weight change, and blood biochemical parameters (alanine aminotransferase (AST), aspartate aminotransferase (ALT) and urea) were evaluated after acute treatment with single doses of SP 1 (27 mg kg -1 , i.p.), with an important antinociceptive effect, or 0.9% saline (i.p.) for 72h. For the in vivo assay, the male mice (6 animals per group) were weighed before the SP 1 (dissolved in After sacrificing the animal, liver, kidney, heart, spleen, thymus and lymph nodes were removed and weighed.
Statistical analyses
All results are presented as mean ± standard error of the mean (S.E.M.). Data from the animals submitted to nociception or open-field tests were analyzed by ANOVA followed by Bonferron's or Student-Newman-Keuls post hoc test. p < 0.05 or p < 0.001 was considered as significant. Student ttest was also used, considering p < 0.05 as significant, when the group of animals that received SP 1 for 72 h on acute assay was evaluated. For these analyses, the software GraphPad Prism (5.0 version) was used.
Results and discussion
The C. cupressoides SPs have been extracted and studied. This species contains three different SPs fractions (SP 1 , SP 2 , and SP 3 ), when eluted at different NaCl concentrations (0.5, 0.75 and 1 M, respectively) on DEAE-cellulose column (RODRIGUES et al., 2011b ). The Table 1 shows the chemical composition of SPs fractions obtained by ion-exchange chromatography (DEAEcellulose) of the C. cupressoides crude polysaccharide extract. According to the quantitative chemical analysis, the S and TSs contents were high in all SP fractions, being the lowest data found for SP 1 , with about 16.93% S and 13.67% TSs, respectively. As also reported, CPs were not detected in the crude extract and SP fractions from this species (RODRIGUES et al., 2011b) . In previous studies, it was demonstrated that only the SP 2 fraction from C. cupressoides showed an anticoagulant activity (in vitro) by the activated partial thromboplastin time test. Fractions SP 1 and SP 3 were not capable of prolonging the coagulation time in vitro (RODRIGUES et al., 2011b . Fraction SP 2 also presented antithrombotic and prothrombotic activities (in vivo) (RODRIGUES et al., 2011b) . Li et al. (2005) reported that the use of anticoagulant SPs in animal studies significantly altered the clotting time, and it could be considered a adverse effect for treating patients subjected to chronic renal diseases, when administrated at high doses (900 and 2500 mg kg -1 , oral administration). Recently, a non-anticoagulant SP, but with in vivo anti-inflammatory effect from five sequential extractions, was obtained from the marine brown alga Lobophora variegata . Based on these hypotheses, we chose the SP 1 (that had higher yield compared with SP 3 ) to be further investigated in nociception and locomotion animal models.
Effect of pretreatment with SP 1 on the acetic acid-induced writhing test
To verify the antinociceptive effect of C. cupressoides, we previously tested SP 1 fraction using the acetic acid-induced writhing test, as shown in Figure 1 This study corroborates the literature that shows seaweeds SPs as molecules capable of reducing the number of abdominal constrictions induced by the acetic acid ASSREUY et al., 2008; VIANA et al., 2002) . Interestingly, the antinociceptive profile of SP 1 (C. cupressoides), when evaluated by acetic acid-induced writhing test (Figure  1) , was similar to that found for Gracilaria cornea (Rhodophyta) SPs by . However, the antinociceptive effects are described uniquely for SPs from red and brown seaweeds (ASSREUY et al., 2008; VIANA et al., 2002) , being rarely reported for SPs from Chlorophyta. SP 1 could inhibit the mediators released in response to chemical stimulus (acetic acid), such as bradykinin, substance P, prostaglandin, and some cytokines, such as IL-1β, TNF-α and IL-8 (COLLIER et al., 1968) .
On the other hand, it has been reported the low specificity of writhing assays (COLLIER et al., 1968) , requiring caution when interpreting the results until the performance of other tests. In order to support this hypothesis, two more complementary tests (formalin and hot-plate) were performed to prove the antinociceptive action of SP 1 .
Effect of pretreatment with SP 1 on the formalin test
In the formalin test, characterized by two phases (Figure 2 ), the mice pretreated (i.v.) with SP 1 (27 mg kg -1 ), injected 30 min prior to 1% formalin, have reduced (p < 0.05) by 51.61% (32.33 ± 3.19 s) the licking time in first phase (neurogenic) from control (67.5 ± 7.26 s) (Figure 2, panel A) . Also, SP 1 (3, 9 or 27 mg kg -1 ) produced a significant inhibition of the formalin response during the second phase (inflammatory) (Figure 2, panel B (Figure 2) VANDERLEI et al., 2010) . Moreover, the late phase seems to be an inflammatory response to inflammatory pain that can be modulated by anti-inflammatory drugs, which inhibit inflammatory mediators, such as serotonin, bradykinin and prostaglandin (HUNSKAAR et al., 1985) . In recent studies, an anticoagulant SP from Champia feldmannii (Rhodophyta) produced a pro-inflammatory effect (ASSREUY et al., 2008) , whereas a nonanticoagulant SP from the brown alga L. variegata was an anti-inflammatory compound . Araújo et al. (2012) reported a crude extract containing ι-carrageenans from Solieria filiformis (Rhodophyta) without anti-clotting effect, but able to inhibit the cellular infiltrate in the peritoneal cavity of rats. There is a lack of structurefunction relationship data concerning the antiinflammatory action of these molecules (POMIN, 2012) .
In this study, the SP 1 (27 mg kg -1 ) also inhibited the first phase (Figure 2 , panel A) compared with saline group, suggesting a possible interaction of this molecule with opioid systems. A similar result was suggested for a SP from S. schroederi (Phaeophyta) and SPs extracted from G. cornea (Rhodophyta) .
Literature describes that the inflammatory hypernociception occurs at least in part as a phenomenon of sensitization of primary afferent nociceptors (MOALEM; TRACEY, 2006). In the inflammatory process, the neutrophils migration occurs in response to mechanical hypernociception, where the release of mediators is observed, such as prostaglandin (CUNHA et al., 2008) . Formalininduced nociception is attributed to an increase in peritoneal fluid levels of several mediators, such as histamine, serotonin, cytokine, and eicosanoid (HUNSKAAR et al., 1985) . The greater antinociceptive effect of SP 1 in the second phase (Figure 2, panel B) could be the result of drugs related to inflammatory pain VANDERLEI et al., 2010) , inhibiting the pain in terms of synaptic transmission at the spinal level in response to formalin-action (HUNSKAAR et al., 1985) . Effect of pretreatment with SP 1 on the hot-plate test
To distinguish between peripheral and central action, SP 1 was also used in the hot-plate test, a specific test of central antinociception in which the opioid agents exert analgesic effects via supra spinal and spinal receptors (EDDY; LEIMBACH, 1953) . C. cupressoides SP 1 did not increase (p > 0.05) the latency of animals (3 mg kg -1 -30 (7.1 ± 1.1 s), 60 (8.2 ± 1.2 s) and 90 (8.7 ± 1.0 s) min.; 9 mg kg -1 -30 (6.9 ± 1.2 s), 60 (7.2 ± 1.1 s) and 90 (8.5 ± 1.2 s) min.; and 27 mg kg -1 -30 (7.3 ± 1.4 s), 60 (8.1 ± 1.2 s) and 90 (9.3 ± 1.3 s) min., respectively) when compared with the saline (at 30 (5.83 ± 1.01 s), 60 (4.5 ± 0.42 s) and 90 (5.16 ± 0.7 s) min., respectively), indomethacin (at 30 (8.4 ± 1.2 s), 60 (8.6 ± 1.3 s) and 90 (9.5 ± 1.1 s) min., respectively), and morphine (at 30 (33.4 ± 0.9 s), 60 (28.6 ± 1.2) and 90 (17 ± 1.1 s) min., respectively) groups, and corroborating thus with the data previously found in the formalin-test that showed antinociceptive effects via peripheral, rather than central-acting mechanisms (Figure 2, panel B) .
Based on these findings, it was suggested that the SP 1 from green seaweed C. cupressoides exhibits antinociceptive effects predominantly through a peripheral mechanism similar to the lectin (protein) isolated from this same species by Vanderlei et al. (2010) . These antinociceptive actions of SP 1 seemed not to be associated with central neurotransmission .
Effect of pretreatment with SP 1 on the open-field test
Once the SP 1 (C. cupressoides) showed antinociceptive effects, it was also explored this molecule on the open-field test, a classic animal model that evaluates autonomic effects and general activity (ARCHER, 1973) . Our data showed that the SP 1 did not induce changes (p > 0.05) in the locomotor activity for number of squares, grooming, and rearing of mice. Diazepam (2 mg kg -1 ) influenced (p < 0.05) the locomotor behavior of the animals ( Table 2) . The parameters analyzed were: number of squares crossed (NSC), grooming (G) and rearing (R). The results are presented as means ± S.E.M. (n = 6). *p < 0.05 compared to control group. (ANOVA and Student-Newman-Keuls post hoc test).
Toxicological evaluation
In order to investigate the safety for 'short term' use of C. cupressoides SP 1 (27 mg kg -1 , i.p., dose selected from antinociceptive assay data obtained in Figure 2 ), a toxicological assay was performed with male Swiss mice for 72h (Table 3 ). The administration with a single injection of SP 1 did not cause animal mortality as well as variation in body mass or wet weight of organs (heart, kidney, liver, thymus, and lymph nodes) compared with saline group.
During the experimental period, some physical and behavior parameters were also observed in animals, such as mucosa or eyes, hair erection, scratching or licking paws, freezing reactions and general behavior. All these aspects were considered normal (ALMEIDA-LIMA et al., 2011; ASSREUY et al., 2008; LI et al., 2005; LINS et al., 2009; MONJI et al., 2011; RODRIGUES et al., 2011c; . Except for the spleen that presented an increase more than 2.5-fold compared with control (p < 0.05) ( Table 2 ), suggesting that SP 1 stimulated the immune function of mice . Probably, SP 1 induced a proliferation of T lymphocytes and production of specific antibodies (LINS et al., 2009; ZHANG et al., 2003) . Furthermore, the histological structure of the spleen of animals treated with SP 1 was essentially preserved (data not shown), based on . Rodrigues et al. (2011c) . Seaweeds have various phytochemicals (ANDRADE et al., 2010; MAO et al., 2011; MARINHO-SORIANO et al., 2006) , including toxic secondary metabolites (MORALES et al., 2006) . In this study, the lack of systemic toxicity in vivo of SP 1 over the considered biochemical parameters could be of pharmacological value (ALMEIDA-LIMA et al., 2011) . Enzymatic extraction performed with papain digestion could also have eliminated any toxic compound in the SP 1 , being consistent with the hypothesis of Heo et al. (2005) .
Seaweeds SPs have also been extensively studied as anticoagulant and antithrombotic agents. Anticoagulant activity of Caulerpa SPs is positively correlated with the sulfate content and charge density (RODRIGUES et al., 2011b ; but, the position of sulfate radicals and/or the occurrence of dissulfated units in the chemical structure of these molecules have also been suggested as requisite for anticoagulant action . However, the toxicity in vivo of these compounds has been little investigated. Li et al. (2005) extracted fucoidan from L. japonica (Phaeophyta) and evaluated the toxicological effects in Wistar rats. The results indicated no toxicity when 300 mg kg -1 body weight per day fucoidan was orally given, but with 900 and 2500 mg kg -1 body weight per day, the clotting time was significantly altered. Fucoidan with strong anticoagulant activity in vivo may have clinical importance. However, it could be considered as limited therapeutic option for the treatment of chronic renal failure. An anticoagulant SP fraction from red alga C. feldmannii was evaluated in mice by i.v administration up to 30 mg kg -1 , and no adverse effect was observed on acute toxicity after 48h (ASSREUY et al., 2008) .
Although SP 1 does not have in vitro anticoagulant effect (RODRIGUES et al., 2011b , algae SPs may also exhibit in vivo actions (LI et al., 2005) . Almeida-Lima et al. (2011) investigated the acute and subchronic toxicity in vivo of a heterofucan (Fucan A), and observed that it practically devoid of anticoagulant activity (in vitro) and hemorrhagic effect (in vivo), but with antithrombotic effect (in vivo) when endovenously injected in the vena cava of Wistar rats. This compound had a pharmacological potential given the absence of toxicity in vivo.
In a previous study, it was demonstrated that an anticoagulant SP fraction (SP 2 , Table 1 ) from C. cupressoides inhibited the thrombin activity by antithrombin (in vitro) (RODRIGUES et al., 2011b) and this interaction mechanism was different from other studied Caulerpa SPs (HAYAKAWA et al., 2000) . In addition, this fraction also inhibited the venous thrombosis and produced prothrombotic activity and no hemorrhagic effect in Wistar rats (RODRIGUES et al., 2011b) . The result of the present study is very important, considering that the heparin, a commercial anticoagulant SP widely used in medical clinic and recognized by its side effects, may induce discrete alterations in the enzymatic activity of aminotransferases in plasma (MAJERUS; TOLLEFSEN, 2005) .
Overall, C. cupressoides features a nonanticoagulant SP fraction (SP 1 ) with antinociceptive effect which seems to be tolerable in mice systematically treated, and representing thus a novel potential source of analgesic compound to be explored in biomedical research. In addition, its analgesic action was observed to be completely dissociated from the absence of anti-clotting action (POMIN, 2012; . New applications of C. cupressoides SPs in 'long term' doses could be of interest from oral administration of future dosage forms, registering the safety profile in repeated dose studies (MONJI et al., 2011) . Additional studies are in progress by our group.
Conclusion
A non-anticoagulant sulfated polysaccharide from the green seaweed Caulerpa cupressoides var. lycopodium has interesting peripheral antinociception without important systemic alterations.
